Risks and Benefits of Antenatal Corticosteroid Therapy Prior to Preterm Birth in Pregnancies Complicated by Fetal Growth Restriction

A. Vidaeff

Abstract:The antepartum administration of fluorinated corticosteroids (bethametasone and dexamethasone) for fetal maturation represents the most important clinical contribution so far in the struggle against prematurity. This treatment reduces the risk of neonatal death and handicap. It is also known that upon corticosteroid exposure, the fetus is subjected to transiently increased physiologic and metabolic demands. Healthy fetuses are able to cope, although, emerging evidence suggests that this may not be the case with severely growth restricted fetuses. Concerns have been raised that corticosteroids administration when preterm delivery is anticipated could be harmful in this setting. A hypoxic growth restricted fetus with diminished reserves may be just coping when unchallenged, but exposure to corticosteroids may tip the balance.